Age, Biography and Wiki
Chang Yi Wang was born on 19 December, 1951 in Taipei; Taiwan, is a Taiwanese immunologist (born 1951). Discover Chang Yi Wang's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is she in this year and how she spends money? Also learn how she earned most of networth at the age of 72 years old?
| Popular As |
N/A |
| Occupation |
N/A |
| Age |
72 years old |
| Zodiac Sign |
Sagittarius |
| Born |
19 December, 1951 |
| Birthday |
19 December |
| Birthplace |
Taipei; Taiwan |
| Nationality |
Taiwan
|
We recommend you to check the complete list of Famous People born on 19 December.
She is a member of famous with the age 72 years old group.
Chang Yi Wang Height, Weight & Measurements
At 72 years old, Chang Yi Wang height not available right now. We will update Chang Yi Wang's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
| Physical Status |
| Height |
Not Available |
| Weight |
Not Available |
| Body Measurements |
Not Available |
| Eye Color |
Not Available |
| Hair Color |
Not Available |
Who Is Chang Yi Wang's Husband?
Her husband is Nean Hu
| Family |
| Parents |
Not Available |
| Husband |
Nean Hu |
| Sibling |
Not Available |
| Children |
Mei Mei Hu |
Chang Yi Wang Net Worth
Her net worth has been growing significantly in 2023-2024. So, how much is Chang Yi Wang worth at the age of 72 years old? Chang Yi Wang’s income source is mostly from being a successful . She is from Taiwan. We have estimated Chang Yi Wang's net worth, money, salary, income, and assets.
| Net Worth in 2024 |
$1 Million - $5 Million |
| Salary in 2024 |
Under Review |
| Net Worth in 2023 |
Pending |
| Salary in 2023 |
Under Review |
| House |
Not Available |
| Cars |
Not Available |
| Source of Income |
|
Chang Yi Wang Social Network
Timeline
Chang Yi Wang (IPA: [tʃɒ̌ŋ jí wɒ́ŋ]) is the founder of United Biomedical, Inc. (UBI), headquartered in Hauppauge, New York, and its group of companies in Asia (including United Biomedical Asia).
Wang was born in Taiwan in 1951.
Her father was a member of the National Assembly.
She was inspired to go into science by the example of physicist Chien-Shiung Wu who disproved the ‘conservation of parity’ theory in 1957.
She graduated with honors from the National Taiwan University in 1973, majoring in organic chemistry.
She was the first Asian woman on the Rockefeller University graduate programme and achieved her Ph.D. degree in 1979 with a dual specialization in Biochemistry and Immunology.
She then joined the Memorial Sloan Kettering Cancer Center as the youngest faculty member, principal investigator, and head of the molecular immunology laboratory.
In 1985, Wang and her husband Nean Hu founded United Biomedical, Inc. in New York - the company’s main focus is on medicine and vaccine development.
She founded United Biomedical, Inc. Asia in Taiwan in 1998.
In 2007, the New York Intellectual Property Law Association (NYIPLA) presented Wang with the Inventor of the Year Award.
In 2009, the Bill and Melinda Gates Foundation awarded Grand Challenges Exploration Grants to Wang for the Synthetic Peptides to Inhibit HIV Entry program.
She later founded United Biopharma and UBI Pharma in 2013 and 2014 respectively.
The companies later created testing for HIV and Hepatitis C, and carried out research on a vaccine for HIV.
In 2018, the Brain Mapping Foundation presented Wang with the Pioneer in Technology Award.
In 2021, Wang was part of a court case which concerned the ownership of UBI, in particular, possible breach of contractual agreements and misuse of authority positions.
Wang’s daughter Mei Mei Hu is the co-founder and CEO of Vaxxinity (originally named Covaxx), a subsidiary of UBI; the company originally focused on possible vaccines for Alzheimer’s and animal health but shifted to working on a vaccine for COVID-19.
The company helped to develop vaccine candidate UB-612.
Wang is the author of more than 120 peer-reviewed scientific publications and by 2019, she was the inventor of more than 80 patents.
